© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#NASH

Green apple and Weight scale,measure tape with fresh vegetable, clean water and sport equipment for women diet slimming
Time-Restricted Eating and Caloric Restriction Have Similar Benefits for NAFLD
Two Experimental Therapies Show Promise for NASH
NASH 101

7th Obesity and NASH Summit

Navigate End-To-End Strategic Updates in NASH and Obesity to Define the Evolving Competitive Landscape in Metabolic Disorders

Fatty Liver Disease Linked to Cardiovascular Risk in People with HIV

NAFLD is associated with risk factors such as obesity and inflammatory biomarkers and with events including heart attacks and strokes.

Is Fatty Liver Disease a Risk Factor for Cardiovascular Disease?

For people with NAFLD or NASH, treating metabolic problems may offer benefits beyond liver disease.

People With NASH Fare Worse Than Those With Diabetes

Advanced fatty liver disease led to a greater need for medical care and more difficulty with daily activities.

NASH Is Major Cause of Liver Cancer Among Transplant Candidates

In 2022, fatty liver disease accounted for nearly a quarter of all liver cancer cases on the transplant waiting list.

Rates of Fatty Liver Disease Are Rising Worldwide

Men, people with obesity and people who smoke are more likely to develop NAFLD.

MUST read

Red Cooler "Human Organ for Transplant"
Fatty Liver Disease–Related Transplants on the Rise Among Young Adults
What Is Fatty Liver Disease And Is It Serious?
liver illustration
Is NASH the Next Hepatitis C?

Lean People With NAFLD May Have Higher Risk of Death

Lean people had a higher mortality rate despite experiencing fewer metabolic problems.

Are you aware of non-alcoholic fatty liver disease (NAFLD/NASH)?

Fatty Liver Disease Increases Among Americans

Obesity-linked liver disease has increased 131% in the past three decades.

Fecal Microbiota Transplant Improves Gut Health in People With Cirrhosis

Restoration of gut function and microbial diversity could lead to improvement of hepatic encephalopathy.

Resmetirom Improves NASH and Liver Fibrosis in Phase III Trial

The findings could potentially lead to the first FDA approval of a treatment for fatty liver disease.

Hot topics

illustration of colorful pills with smile and frown faces
NAFLD/NASH Medication Drug Chart
What are the symptoms of NAFLD/NASH?

Liver Cirrhosis and Related Mortality Are Projected to Rise

While hepatitis C remains a leading cause, cirrhosis is increasingly caused by fatty liver disease and alcohol use.

Liver Basics

Statins Linked to Lower Risk of Liver Disease Progression

People who used cholesterol-lowering medications had a 40% lower risk for liver disease progression.

Weight-Loss Surgery Linked to Lower Cardiovascular Risk in People With NAFLD

The risk for cardiovascular events and all-cause mortality were greatly reduced in people with obesity and fatty liver disease.

Experts Advise Against Approval of Obeticholic Acid for NASH

An FDA advisory committee expressed concerns about the safety of the fatty liver disease treatment.
Advertisement
Science News
Features

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.